MENU
TNGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tango Therapeutics (TNGX) Ownership - Who owns Tango Therapeutics?
Tango Therapeutics Inc is a biotechnology company... Show more
Profile
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
157.84M
P/E Ratio
N/A
Total Cash
257.92M
Projected Growth
N/A
Total Debt
36.49M
Revenue
42.07M
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash/Share
2.39
Total Debt/Equity
N/A
Revenue/Share
0.39 USD as % of share price
Fundamentals
TNGX
Capitalization
158M
P/E Ratio
N/A
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash
258M
Total Cash/Share
2.39
Total Debt
36.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.39%
Revenue
42.1M
ROE
N/A
Book Value
200M
P/B Ratio
0.79
Cash Flow
N/A
Earnings
-1.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
108K
Current Ratio
6.98
Current Revenue Per Employee
26561.29
Dividends Per Share - Security
N/A
EBITDA
-143.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.24
Shares Held By Institutions
474M
Shares Outstanding - Current
108M
Total Liabilities
117M
Total Volume MTD
N/A
Value
1
Gain YTD
-52.751
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com